Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • yasu
    Member
    • Jul 2009
    • 10

    #1

    cuffcompare output statistic

    I got cuffcompare output something like below:

    ==================
    # Query mRNAs : 250371 in 250079 loci (24778 multi-exon transcripts)
    # (282 multi-transcript loci, ~1.0 transcripts per locus)
    # Reference mRNAs : 39609 in 25783 loci (31869 multi-exon)
    # Corresponding super-loci: 14405
    #--------------------| Sn | Sp | fSn | fSp
    Base level: 53.1 38.8 - -
    Exon level: 0.7 0.5 20.3 15.7
    Intron level: 0.0 0.0 12.6 74.2
    Intron chain level: 0.0 0.0 0.2 0.3
    Transcript level: 0.0 0.0 0.0 0.0
    Locus level: 0.0 0.0 0.3 0.0
    Missed exons: 97628/219296 ( 44.5%)
    Wrong exons: 164116/283022 ( 58.0%)
    Missed introns: 163909/193288 ( 84.8%)
    Wrong introns: 5780/32915 ( 17.6%)
    Missed loci: 10965/25783 ( 42.5%)
    Wrong loci: 154875/250079 ( 61.9%)

    Total union super-loci across all datasets: 170453
    (0 multi-transcript, ~0.0 transcripts per locus)
    ==================

    I'd like to know the meaning of each statistic. Specifically, can I think that this data covers 14818 loci (calculated from 25783-10965 as shown in "Missed loci") at least one read?

    I tried to look around related thread, but I cannot find out. Sorry for redundant thread if there are already related ones.

    Thanks in advance.

    -Yasu
  • sterding
    Member
    • Sep 2010
    • 36

    #2
    I have the same question. The 'base-level' Sn/Sp is reasonablly high, while the exon-level Sn/Sp is very low. Why like this?

    Comment

    • Yt Shen
      Junior Member
      • Oct 2012
      • 3

      #3
      Dear sterding and yasu,

      Did any of you get the information about the topic you talk about above? I also confused about it.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...